Morgan Stanley’s LAVA Therapeutics LVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.3K | Sell |
11,600
-200
| -2% | -$264 | ﹤0.01% | 6730 |
|
|
2025
Q1 | $15K | Buy |
11,800
+3,300
| +39% | +$4.19K | ﹤0.01% | 6665 |
|
|
2024
Q4 | $8.08K | Sell |
8,500
-27,900
| -77% | -$26.5K | ﹤0.01% | 6874 |
|
|
2024
Q3 | $60.4K | Buy |
36,400
+20,800
| +133% | +$34.5K | ﹤0.01% | 6159 |
|
|
2024
Q2 | $28.1K | Buy |
15,600
+5,400
| +53% | +$9.72K | ﹤0.01% | 6358 |
|
|
2024
Q1 | $34K | Sell |
10,200
-39,400
| -79% | -$131K | ﹤0.01% | 6348 |
|
|
2023
Q4 | $78.4K | Buy |
49,600
+39,300
| +382% | +$62.1K | ﹤0.01% | 6238 |
|
|
2023
Q3 | $15.1K | Buy |
10,300
+100
| +1% | +$147 | ﹤0.01% | 6571 |
|
|
2023
Q2 | $20.7K | Buy |
10,200
+1,300
| +15% | +$2.64K | ﹤0.01% | 6555 |
|
|
2023
Q1 | $14.8K | Buy |
8,900
+1,909
| +27% | +$3.17K | ﹤0.01% | 6737 |
|
|
2022
Q4 | $24.5K | Buy |
6,991
+1,991
| +40% | +$6.97K | ﹤0.01% | 6600 |
|
|
2022
Q3 | $23K | Sell |
5,000
-700
| -12% | -$3.22K | ﹤0.01% | 6733 |
|
|
2022
Q2 | $17K | Buy |
5,700
+2,900
| +104% | +$8.65K | ﹤0.01% | 7048 |
|
|
2022
Q1 | $12K | Sell |
2,800
-1,525
| -35% | -$6.54K | ﹤0.01% | 7350 |
|
|
2021
Q4 | $24K | Buy |
+4,325
| New | +$24K | ﹤0.01% | 7144 |
|